Hong Yuan Holding Group Statistics
Total Valuation
HGYN has a market cap or net worth of 2.77 million. The enterprise value is 2.85 million.
| Market Cap | 2.77M |
| Enterprise Value | 2.85M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HGYN has 74.64 million shares outstanding.
| Current Share Class | 74.64M |
| Shares Outstanding | 74.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.95 |
| PB Ratio | -18.90 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78
| Current Ratio | 0.78 |
| Quick Ratio | 0.53 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.12 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -12.21% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 63.50% |
| Weighted Average Cost of Capital (WACC) | 24.44% |
| Revenue Per Employee | 55,973 |
| Profits Per Employee | -9,996 |
| Employee Count | 10 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 5.87 |
Taxes
In the past 12 months, HGYN has paid 7,686 in taxes.
| Income Tax | 7,686 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +48.40% in the last 52 weeks. The beta is 3.68, so HGYN's price volatility has been higher than the market average.
| Beta (5Y) | 3.68 |
| 52-Week Price Change | +48.40% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 47.08 |
| Average Volume (20 Days) | 10,355 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, HGYN had revenue of 559,734 and -99,963 in losses. Loss per share was -0.00.
| Revenue | 559,734 |
| Gross Profit | 370,818 |
| Operating Income | -91,584 |
| Pretax Income | -91,638 |
| Net Income | -99,963 |
| EBITDA | -86,153 |
| EBIT | -91,584 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 13,365 in cash and 4,460 in debt, with a net cash position of 8,905 or 0.00 per share.
| Cash & Cash Equivalents | 13,365 |
| Total Debt | 4,460 |
| Net Cash | 8,905 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | -146,510 |
| Book Value Per Share | -0.00 |
| Working Capital | -174,082 |
Cash Flow
| Operating Cash Flow | -37,819 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 5,431 |
| Net Borrowing | n/a |
| Free Cash Flow | -37,819 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 66.25%, with operating and profit margins of -16.36% and -17.86%.
| Gross Margin | 66.25% |
| Operating Margin | -16.36% |
| Pretax Margin | -16.37% |
| Profit Margin | -17.86% |
| EBITDA Margin | -15.39% |
| EBIT Margin | -16.36% |
| FCF Margin | n/a |
Dividends & Yields
HGYN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.61% |
| FCF Yield | -1.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HGYN has an Altman Z-Score of -213.01 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -213.01 |
| Piotroski F-Score | 3 |